Shen Ai Xie

Shen Ai XieShen Ai Xie
Shen Ai Xie

Shen Ai Xie

Camera-based health monitoring SDK for non-invasive vital sign assessment.

DR 0Active37
Rate

About

Shen AI provides a camera-based health monitoring platform that enables the measurement of over 30 health markers, including vital signs and health indices, through a 30-second face scan. Their technology utilizes computer vision and AI for 100% video processing, offering clinically validated and reliable health insights without requiring wearables. This solution is built for healthcare and insurance leaders, integrating into mobile or web applications for use in telehealth, corporate wellness, and remote patient monitoring.
Frequently asked

What does Shen Ai Xie do?

Shen AI provides a camera-based health monitoring platform that enables the measurement of over 30 health markers, including vital signs and health indices, through a 30-second face scan. Their technology utilizes computer vision and AI for 100% video processing, offering clinically validated and reliable health insights without requiring wearables. This solution is built for healthcare and insurance leaders, integrating into mobile or web applications for use in telehealth, corporate wellness,…

What is Shen Ai Xie's revenue?

StartupHub estimates Shen Ai Xie's annual revenue at $3.4M (range $2.0M to $11.7M, 62% confidence), based on comparable companies in the sector.

What is Shen Ai Xie's valuation?

StartupHub estimates Shen Ai Xie's effective valuation at $7.8M (range $5.0M to $12.0M, 10% confidence), based on comparable companies in the sector.

How much funding has Shen Ai Xie raised?

Shen Ai Xie has raised a total of $2M in funding. The most recent round on record is Seed.

What industry does Shen Ai Xie operate in?

Shen Ai Xie operates in API Platform, MLOps, Developer Tools, Foundation Model, Generative AI, AI Infrastructure.

How many employees does Shen Ai Xie have?

Shen Ai Xie has approximately 37 people on record.

HEADCOUNT
37
DOMAIN RATING
0
Comments

No comments yet. Be the first to share your take.